Pharmaceutics International, Inc. disclosed a data security incident to the New Hampshire Attorney General on December 22, 2025, triggering legally mandated notification letters. If you are one of the people who received Pharmaceutics International, Inc.'s letter, your data may have been exposed and you could be entitled to compensation.
The New Hampshire Attorney General filing confirms the breach notice — not a court case. Where no court record exists, no settlement figure or deadline is shown. Legal outcomes cannot be predicted or promised.
The official New Hampshire AG notice for Pharmaceutics International, Inc. identifies the following exposed data:
Each exposed category makes the claim stronger. Courts treat unauthorized disclosure of this information as actionable harm.
Pharmaceutics International, Inc. operates as a specialized contract development and manufacturing organization (CDMO) within the highly regulated life sciences and pharmaceutical sector. The company provides formulation development, analytical testing, clinical trial manufacturing, and commercial production services for major pharmaceutical and biotechnology firms. Because of its core operations, Pharmaceutics International occupies a vital yet sensitive position in the healthcare and pharmaceutical supply chain, maintaining extensive networks and data repositories that intersect with both commercial drug development and healthcare delivery.
In 2025, Pharmaceutics International, Inc. reported a significant cybersecurity incident to the New Hampshire Attorney General, triggering mandatory breach notifications to impacted individuals. Within the pharmaceutical and life sciences sector, security incidents of this magnitude typically involve sophisticated cyberattacks, such as ransomware deployments, unauthorized intrusion into proprietary database networks, or compromises within third-party vendor ecosystems. Given the intellectual property and sensitive administrative data inherent to pharmaceutical manufacturing, threat actors increasingly target these environments to exfiltrate proprietary research, corporate records, and internal personnel files.
The data compromised in incidents involving organizations like Pharmaceutics International routinely includes sensitive personally identifiable information (PII) belonging to employees, clinical trial participants, and business partners. Exposed categories frequently encompass full names, dates of birth, Social Security numbers, banking and payroll details, and potentially specialized health-related records. The exposure of this information creates severe, long-term risks for victims. Social Security numbers and dates of birth serve as the foundational keys for identity theft, tax fraud, and unauthorized credit applications, while financial and direct deposit details leave victims immediately vulnerable to account takeover and unauthorized fund transfers.
As an entity handling sensitive personal and employment data, Pharmaceutics International, Inc. was bound by stringent legal obligations under state data protection statutes, common law duties of care, and applicable federal regulations such as the Federal Trade Commission Act. These legal frameworks mandate the implementation of robust administrative, technical, and physical safeguards—including multi-factor authentication, network segmentation, regular vulnerability testing, and prompt patching of known system flaws. The occurrence of a data breach capable of exfiltrating sensitive PII strongly suggests systemic failures in maintaining these mandatory security protocols, raising serious questions regarding negligence and inadequate data protection.
Receiving a formal data breach notification letter from Pharmaceutics International, Inc. represents more than just a routine administrative notice; it serves as a formal legal admission that the company failed to safeguard your confidential personal information. Under modern legal standards, the receipt of this notice establishes the concrete injury and legal standing required to participate in a class action lawsuit aimed at holding the company accountable. Affected individuals do not need to demonstrate actual financial loss or identity theft to seek legal redress. Our firm evaluates and investigates these data breach matters on a strict contingency fee basis, meaning you pay nothing out of pocket and owe no legal fees unless we successfully recover compensation on your behalf.
Financial harm is not a requirement. The exposure of your personal information is itself recognized as actionable. Check the list — most letter recipients qualify under at least one item:
You received a data breach notification letter from Pharmaceutics International, Inc.
You were a customer, patient, employee, or client of Pharmaceutics International, Inc.
Your personal information was stored in Pharmaceutics International, Inc.'s systems
Your Social Security number or driver's license number was exposed
Your financial account, credit card, or banking information was disclosed
You reside in the United States (all 50 states eligible)
That letter is legally required and confirms your data was exposed. It also gives you standing to file a claim.
What your notification letter means & what to do next →Do these four things as soon as possible; each one protects you and strengthens any claim:
Do not discard the Pharmaceutics International, Inc. letter. It documents your standing as an affected individual — the foundation of any claim you file.
Check your Pharmaceutics International, Inc. letter for credit-monitoring enrollment instructions and use them. Free monitoring catches fraud early and documents harm.
Place security freezes at all three bureaus — Equifax, Experian, TransUnion. New-account fraud dies at the freeze; you can unfreeze temporarily for legitimate applications.
Claims windows close. Our team reviews Pharmaceutics International, Inc. breach cases free of charge and works on contingency — you pay nothing unless we recover for you.
Security Incident
Prior to AG notification
Pharmaceutics International, Inc.'s systems were compromised, exposing stored personal records.
Reported to Attorney General
December 22, 2025
Pharmaceutics International, Inc. filed its official breach notice with the New Hampshire Attorney General.
Consumer Notification Letters Sent
Within weeks of AG filing
State law obligates companies to mail notification letters to everyone affected.
Legal Window — Act Now
Statute of limitations applies
Legal deadlines limit how long you have to act on this breach.
Breach victims may recover several categories of loss. What applies in the Pharmaceutics International, Inc. matter depends on your state, the data involved, and the company's conduct.
Statutory damages exist independent of out-of-pocket loss — California's $100–$750 range is the model other states have followed.
If the breach led to fraudulent charges or unauthorized transactions on your accounts, those losses are recoverable.
Compensation for hours spent monitoring accounts, disputing fraud, freezing credit, and dealing with the aftermath of the breach.
Reimbursement for the cost of credit monitoring services, identity theft protection, and related identity restoration expenses.
SSN and driver's license exposure creates long-term identity theft risk. Courts recognize the ongoing value of this harm and may award damages accordingly.
Exposure of financial account or credit/debit card information entitles victims to recover for actual and potential fraud losses.
New Hampshire's breach notification law (RSA 359-C) requires timely notice to affected individuals and the Attorney General. New Hampshire residents may pursue civil action for actual damages and attorney's fees stemming from inadequate data protection.
The companies below also filed breach notices with the New Hampshire Attorney General. Letter recipients for any of them can pursue a review.
One Medical
New Hampshire · Jul 2026
Town of Canterbury, NH
New Hampshire · Jun 2026
Center for Advanced Eye
New Hampshire · Jun 2026
West Series of Lockton Companies, LLC
New Hampshire · Jun 2026
Easterly Government Properties, Inc.
New Hampshire · Jun 2026
Open Arms Care Corporation
New Hampshire · Jun 2026
Contact us for a FREE consultation. No fee unless we win your case.
(786) 306-7278Free Claim ReviewLaw Office of David S. Harris